RESUMO
ABSTRACTEmpirical antifungal therapy is most often given to patients with leukemia. However breakthrough fungal infections under antifungal therapy are not uncommon. Four children, with hematologic malignant disease developed mycotic breakthrough infections while on empirical caspofungin treatment for a median of 14 (range 11-19) days. Trichosporon asahii was detected in the blood culture of two patients and Geotrichum capitatum in the other two (one patient also had positive cerebrospinal fluid culture). Because the patients' clinical situation worsened, voriconazole was empirically added for two patients three and five days before the agent was detected. The first sterile blood culture was obtained 3-7 days of voriconazole treatment. All patients reached clear cultures but one patient died. One patient with central nervous system infection with G. capitatum had severe neurological sequelae. Very severe fungal infections can occur during empirical caspofungin therapy. Therefore, patients should be followed closely.
Assuntos
Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Antifúngicos/uso terapêutico , Equinocandinas/uso terapêutico , Neutropenia Febril/tratamento farmacológico , Geotricose/diagnóstico , Micoses/diagnóstico , Tricosporonose/diagnóstico , Neutropenia Febril/microbiologia , Geotricose/microbiologia , Micoses/microbiologia , Doenças Raras , Índice de Gravidade de Doença , Tricosporonose/microbiologiaRESUMO
Brevibacterium spp. are catalase-positive, non-spore-forming, non motile, aerobic Gram- positive rods that were considered apathogenic until a few reports of infections in immunocompromised patients had been published. To the best of our knowledge, this is the first report of B. casei catheter-related bloodstream infection in a child with acute leukemia. We aim to enhance the awareness of pediatric hematology and infectious disease specialists about this pathogen and review of the literature.